2 recruiting. 1 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Recruiting 1 |
| Phase 2 | 1 | Recruiting 1 |
Follow Polina Stepensky: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study of HBI0101 (NXC-201) CAR-T Therapy in Multiple Myeloma and Light-Chain Amyloidosis HBI0101 CART - Multiple Myeloma, Refractory to Standard Treatment, Multiple Myeloma, Relapsed | Phase 2 | Recruiting | Polina Stepensky | 180 | 2025-03-01 | 2025-05-14 |
| Phase 1 Study of HBI0101 CAR-T in Refractory B-Cell Autoimmune Diseases HBI0101 CART - Systemic Sclerosis (SSc), Idiopathic Inflammatory Myopathy (IIM) | Phase 1 | Recruiting | Polina Stepensky | 120 | 2024-09-01 | 2026-05-06 |
Antiphospholipid Syndrome (1) · Arthritis, Rheumatoid (1) · Immunoglobulin Light-chain Amyloidosis (1) · Lupus Erythematosus, Systemic (1) · Multiple Myeloma (1) · Multiple Sclerosis (1) · Multiple Sclerosis, Chronic Progressive (1) · Myasthenia Gravis (1) · Myositis (1) · Neuromyelitis Optica (1) · Recurrence (1) · Scleroderma, Systemic (1)
Israel (2)